Anti-inflammatory Therapeutics Market Size to Hit US$ 149.5 billion by 2031 | Exclusive Study by Transparency Market Research

With the introduction of new drugs and advances in technology, demand is expected to rise. Telemedicine and advanced diagnostics will continue to drive the market

WILMINGTON, Del., Oct. 30, 2023 /PRNewswire/ -- The anti-inflammatory therapeutics market was worth US$ 94.6 billion in 2022. In 2031, the market is expected to reach US$ 149.5 billion. Between 2023 and 2031, the market is expected to register a CAGR of 5.1%. With the development of targeted therapies and drug delivery systems, anti-inflammatory treatments are becoming more effective, thereby gaining popularity among patients and healthcare providers.

Download PDF Brochure: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1907

The accessibility and affordability of non-steroidal anti-inflammatory drugs (NSAIDs) make them popular for the management of pain and inflammation. Due to the common use of these drugs, both over-the-counter and prescription drugs have driven market growth. Funding from governments and other organizations plays a critical role in the advancement of the inflammatory diseases market. Pharma companies are encouraged by these initiatives to invest in research and development in order to stay competitive.

Since emerging economies have developed their healthcare infrastructure, anti-inflammatory therapies are becoming more accessible. The availability and affordability of these treatments contribute to market expansion. Patients' satisfaction and treatment outcomes can be improved when physicians customize anti-inflammatory treatments specifically to them. Over 1.3 million Americans suffer from rheumatoid arthritis, according to the Rheumatoid Arthritis Support Network. Nearly 1% of the global population suffers from this disease.

Anti-inflammatory Therapeutics Market Report Scope:

Key Findings of Market Report

• 74% of the global market share for anti-inflammatory therapeutics was accounted for by anti-inflammatory biologics in 2022.
• Among the applications of anti-inflammatory therapeutics, auto-immune diseases will lead the global market.
• North America is expected to dominate the global anti-inflammatory therapeutics market.
• Among anti-inflammatory therapeutics, injections are expected to account for a significant global market share.
• Based on distribution channels, hospital pharmacies will dominate the global market.

Anti-inflammatory Therapeutics Market Drivers

• The increased incidence and severity of inflammatory diseases, such as rheumatoid arthritis and inflammatory bowel disease is driving anti-inflammatory therapeutics. A growing global population and changing lifestyles continue to increase the incidence of these diseases, resulting in a higher demand for anti-inflammatory drugs.
• The prevalence of inflammatory conditions increases with age. In order to manage age-related conditions such as osteoarthritis, anti-inflammatory drugs are increasingly in demand as the global population ages. The pharmaceutical industry continually develops new anti-inflammatory drugs, improving their efficacy and reducing their side effects.
• The advancement of these treatments attracts consumers and healthcare providers, resulting in a growth in the market. Inflammatory conditions are becoming more prevalent and can be detected earlier, which leads to a higher prescription rate for anti-inflammatory drugs. The management of these conditions has become more proactive among both patients and doctors, resulting in the expansion of this market.

Enquiry Before Buying @ https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=1907 

Global Market for Anti-inflammatory Therapeutics Regional Outlook

• North America is projected to drive global market growth over the forecast period. Several associated risk factors are increasing the prevalence of inflammation, and approved anti-inflammatory drugs are propelling the growth of the anti-inflammatory therapeutics market in North America. Increasing geriatric populations and chronic illnesses will drive demand for these therapies.
• Increasing research and development activities for developing innovative medicines in the Asia-Pacific is expected to grow demand for the market. Asia-Pacific has seen a steady growth in the anti-inflammatory therapeutics market driven by the prevalence of inflammation-causing diseases, including psoriasis, arthritis, and respiratory conditions. New drugs can be evaluated for safety and efficacy through extensive research through preclinical and clinical trials. By addressing medical needs, improving treatment outcomes, and enhancing patient care, such innovations create new anti-inflammatory drugs.

Global Anti-inflammatory Therapeutics: Key Players

Established players in a highly fragmented global industry dominate the industry. Top players in the global anti-inflammatory therapeutics market have achieved increasing market share through strategies such as product portfolio expansion and mergers and acquisitions. Key market players in the anti-inflammatory therapeutics landscape include:

• AbbVie Inc.
• Merck & Co. Inc.
• Johnson & Johnson Services, Inc.
• Pfizer, Inc.
• Novartis AG
• GlaxoSmithKline plc.
• Amgen, Inc.
• F. Hoffmann-La Roche Ltd.
• AstraZeneca
• Sanofi

Key Developments in the Global Anti-inflammatory Therapeutics Market

• On July 24, 2023, AbbVie Inc. reported that the first patient had been dosed in the phase 3 Step-Up HS study evaluating upadacitinib (RINVOQ) in patients with mild to moderate hidradenitis suppurativa (HS) adverse reactions to TNF inhibitors and/or non-TNF inhibitors.
• On May 18, 2023, AbbVie Inc. released a statement that the U.S. Food and Drug Administration (FDA) approved RINVOQ (upadacitinib) as a treatment for adults with moderate to severe active Crohn's disease reacting poorly to TNF blockers and intolerance to them.

Global Anti-inflammatory Therapeutics Market: Segmentation

Drug Class

• Anti-inflammatory Biologics
• NSAIDs
• Others

Application

• Auto-immune Diseases
  • Rheumatoid Arthritis
  • Psoriasis
  • Multiple Sclerosis
  • Crohn's Disease
  • Ulcerative Colitis
  • Others
• Respiratory Conditions
  • COPD
  • Asthma
• Others

Route of Administration

• Oral
• Injection
• Topical
• Inhalation

Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Region

• North America
• Latin America
• Europe
• Asia Pacific
• Middle East & Africa

Place an Order Copy of Anti-inflammatory Therapeutics Market Report at:  https://www.transparencymarketresearch.com/checkout.php?rep_id=1907&ltype=S 

Browse Similar Report

Anti-Inflammatory Peptides Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2020-2030

Non-steroidal Anti-inflammatory Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 – 2025

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact:

Nikhil Sawlani
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com   
Blog: https://tmrblog.com   
Email: sales@transparencymarketresearch.com

Logo: https://mma.prnewswire.com/media/1682871/TMR_Logo_Logo.jpg